Journal menu

Editorial Board

At Confmeets Journals, the Editorial Board serves as the cornerstone of academic integrity and excellence. Comprising distinguished scholars and professionals across various disciplines, the board ensures that each manuscript undergoes a rigorous peer-review process aligned with the journal's mission.

Our board members are committed to upholding the integrity, quality, and ethical standards of scholarly publishing. They collaborate closely with authors, reviewers, and the Confmeets editorial team to uphold ethical practices, promotes transparency, and guarantee that every published article contributes meaningfully to the advancement of knowledge in its field.

Editor-in-Chief

Prof Laila M Montaser

Prof Laila M Montaser MD

Editor-in-Chief

Department of Clinical Pathology

Menoufia University, Shibin El Kom

Laila M. Montaser MD is a Prof. of Clinical Pathology. Chair, Stem Cell, Regenerative Medicine, Nanotechnology and Tissue Engineering (SRNT) Research Group. She served as the Chair, Founder leader of Clinical Pathology Department at Menoufia Faculty of Medicine. She supervised 47 M. Sc. theses and 13 Doctoral theses. She has 239 International publications in world journals and global conferences and given about 100 Plenary/keynote presentations on four continents. In the era of COVID-19, she was awarded 54 certificates of appreciation for successfully presenting 60 Global conferences from her home office. A certificate of thanks and appreciation was given to her at Menoufia University's forty-seventh annual anniversary on December 25th, 2023. She has made the Faculty of Medicine Menoufia University a beacon in the globe.

Editorial Members

Say Sreypich

Say Sreypich Ph.D.

Editorial Member

University of Puthisastra, Phnom Penh

Department of Pharmacy

Dr. Say Sreypich is currently serving as a full-time faculty member in the Master’s Program at the University of Puthisastra, Cambodia. She previously held a postdoctoral research position at the School of Medicine, Keio University, Japan. Dr. Sreypich earned her Doctor of Philosophy in Engineering, majoring in Biomedical Science and Engineering, from Tokyo Medical and Dental University, Japan, in 2024. She also holds a Master’s degree in Chemical Engineering from De La Salle University, Philippines (2018), and an Engineering degree in Chemical Engineering and Food Science from the Institute of Technology of Cambodia (2011). Her research interests lie in the development of biomaterials for medical applications, particularly through decellularization technology, 3D printing, and hydrogel formation. She is also actively engaged in the study of biomaterials under in vitro, in vivo, and ex vivo conditions, with a focus on their mechanical and surface properties.

Dr Joy Kong

Dr Joy Kong MD

Editorial Member

Chara Health, California

Department of Integrative Cell Therapy

Joy Kong, M.D. is a UCLA-trained, triple board-certified physician (American Board of Psychiatry & Neurology, American Board of Addiction Medicine, American Board of Anti- Aging & Regenerative Medicine). She is the president of Chara Health in Los Angeles, California, where she specializes in stem cell therapy, ketamine therapy, as well as a wide range of therapeutic modalities to improve patients’ overall health by enhancing their body’s innate regenerative potentials.Dr. Kong is an avid educator and the founder of American Academy of Integrative Cell Therapy, where she provides training and mentorship to physicians in the arena of stem cell therapy. Dr.Kong is keen in her pursuit of evidence-based medicine, and is a published author in scientific journals. Dr. Kong is a sought-after speaker nationally and internationally. and is a faculty member for International Society for Stem Cell Application (ISSCA) - the largest international stem cell training organization that has trained thousands of physicians worldwide. In an effort to provide her patients with the best regenerative medicine products, Dr. Kong founded Chara Biologics, where she developed the most potent and comprehensive stem cell product in the country with a patent-pending formulation, as well as a 100% natural stem cell skin cream CharaOmni. Dr. Kong was recognized for her contribution to the field of regenerative medicine and awarded the "Top Doctor of the Year in Stem Cell Therapy” in 2019 as well as “Stem Cell Doctor of the Decade” in 2021 by the prestigious IAOTP (International Association of Top Professionals). Dr. Kong’s memoir Tiger of Beijing has garnered tremendous interest, and was named “2020 Book of the Year” and showcased at Times Square. Dr. Kong was also featured in the 2021 book HEROES, LEADERS, LEGENDS: the Power of the Human Spirit, along with movers and shakers such as Oprah Winfrey, Deepak Chopra and Maya Angelo.

Awards Nomination 12+ Million Readerbase

Indexed In

Open J Gate Genamics JournalSeek RefSeek Hamdard University EBSCO A-Z OCLC- WorldCat Publons Geneva Foundation for Medical Education and Research Euro Pub Google Scholar